Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis

The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Gastroenterology & Hepatology in conversation with
Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis
Apr 09, 2025
The Lancet Group

How does acute kidney injury presentation and management differ globally for patients hospitalised with cirrhosis? 

We spoke to Salvatore Piano, corresponding author of the landmark International Club of Ascites GLOBAL AKI study, about new data on regional variations in severity, phenotype, treatment, and outcomes across 5 continents.

Read the full article:

https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00006-8/fulltext?dgcid=buzzsprout_icw_podcast_generic_langas

Continue this conversation on social!

Follow us today at...

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv

Episode Artwork Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis 19:05 Episode Artwork John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer 13:29 Episode Artwork Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes 21:23 Episode Artwork Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures 11:15 Episode Artwork Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis 14:42 Episode Artwork Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease 34:15 Episode Artwork Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer 18:23 Episode Artwork Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy 25:05 Episode Artwork Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS 23:16 Episode Artwork Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease 19:55 Episode Artwork Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa 20:54 Episode Artwork Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake 16:39 Episode Artwork Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity 23:19 Episode Artwork Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region 14:40 Episode Artwork Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy 14:45 Episode Artwork Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease 16:19 Episode Artwork Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction 16:31 Episode Artwork Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis 14:29 Episode Artwork Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease 17:41 Episode Artwork Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis 12:48 Episode Artwork Adelina Artenie on the incidence of HIV and HCV in people who inject drugs 17:15 Episode Artwork Johan Burisch on the costs of inflammatory bowel disease in high-income settings 20:00 Episode Artwork Edouard Louis on the SPARE trial of infliximab or immunosuppressant withdrawal in Crohn’s disease 21:30 Episode Artwork Paula Ghaneh on the ESPAC5 trial of neoadjuvant therapy in borderline resectable pancreatic cancer 20:20 Episode Artwork Dan Turner on vedolizumab in children with IBD 14:51